frederick
g
hayden
md
facp
cute
viral
respiratori
infect
vri
encompass
rang
ill
togeth
constitut
frequent
infect
human
preval
syndrom
character
sign
symptom
common
cold
acut
viral
rhinosinus
ill
typic
acut
selflimit
event
associ
primarili
upper
respiratori
symptom
also
caus
symptom
indic
lower
respiratori
involv
particularli
young
elderli
preexist
airway
diseas
rhinovirus
common
pathogen
caus
vri
account
approxim
cold
annual
basi
surprisingli
recent
develop
antivir
compound
activ
target
rhinovirus
intensifi
interest
infect
supplement
contain
seri
articl
base
present
intern
regard
expert
met
april
philadelphia
pennsylvania
discuss
current
knowledg
recent
advanc
regard
epidemiolog
clinic
impact
pathogenesi
manag
rhinovir
vri
children
get
averag
cold
annual
preschool
children
get
averag
per
year
may
get
per
year
incid
decreas
age
averag
cold
per
year
adulthood
data
survey
conduct
nation
center
health
statist
report
million
case
cold
requir
form
treatment
survey
also
show
cold
associ
million
day
restrict
activ
approxim
million
day
miss
work
million
day
miss
school
million
day
individu
bedridden
gonzal
et
al
report
million
offic
visit
primari
care
provid
upper
respiratori
tract
infect
furthermor
cost
associ
common
cold
estim
exceed
billion
per
year
unit
state
anoth
import
factor
contribut
cost
vri
use
antibiot
common
cold
relat
vri
syndrom
among
frequent
reason
inappropri
antibiot
use
unit
state
increas
cost
ill
unnecessarili
contribut
increas
preval
antibioticresist
bacteria
center
diseas
control
prevent
estim
approxim
million
cours
antibiot
prescrib
officebas
physician
year
unnecessari
estim
million
antibiot
prescript
written
annual
upper
respiratori
infect
cost
million
regard
common
attribut
rhinoviru
infect
discolor
nasal
discharg
postnas
drainag
significantli
associ
antibiot
prescrib
furthermor
even
though
physician
awar
lack
benefit
antibiot
infect
survey
shown
physician
much
like
prescrib
antibiot
believ
patient
expect
receiv
howev
physician
also
overestim
desir
patient
antibiot
given
substanti
person
societ
impact
vri
develop
safe
effect
antivir
compound
specif
target
common
pathogen
involv
would
repres
major
advanc
field
respiratori
infect
picornaviru
famili
includ
import
respiratori
pathogen
major
group
caus
vri
rhinovirus
consist
serotyp
enterovirus
compris
approxim
antigen
type
rhinovirus
caus
cold
enterovirus
caus
vri
rhinovirus
primari
etiolog
agent
common
cold
also
caus
complic
involv
upper
lower
respiratori
tract
includ
otiti
media
particularli
children
sinus
exacerb
asthma
form
airway
diseas
chronic
obstruct
pulmonari
diseas
copd
cystic
fibrosi
addit
rhinovirus
caus
seriou
lower
respiratori
diseas
certain
popul
includ
infant
young
children
elderli
person
immunocompromis
patient
unfortun
mani
clinic
microbiolog
laboratori
use
optim
techniqu
detect
rhinoviru
infect
remain
underappreci
pathogen
techniqu
cultur
avail
clinic
use
timefram
also
recent
develop
polymeras
chain
reaction
pcr
techniqu
sensit
rhinoviru
identif
avail
research
facil
supplement
dr
arnold
monto
begin
review
epidemiolog
studi
assess
agerel
rate
respiratori
ill
pathogen
involv
season
well
mode
transmiss
rhinoviru
infect
studi
confirm
rhinovirus
caus
major
common
cold
particularli
advanc
techniqu
appli
viral
rna
detect
reversetranscript
pcr
test
also
report
yearround
occurr
rhinoviru
ill
peak
fall
spring
temper
climat
highlight
import
children
introduc
infect
household
inform
import
target
specif
antivir
therapi
vri
result
picornavirus
viral
respiratori
pathogen
second
articl
dr
jack
gwaltney
jr
discuss
emerg
inform
pathogenesi
infect
rhinovirus
rhinoviru
infect
effici
infecti
dose
quit
small
immunolog
suscept
host
furthermor
symptom
develop
rapidli
within
hour
infect
experiment
condit
relat
viral
induc
host
respons
includ
releas
inflammatori
mediat
neurogen
reflex
knowledg
pathogenesi
import
time
therapeut
approach
find
highlight
import
antivir
therapi
address
primari
caus
ill
earli
intervent
within
first
day
symptom
onset
order
reduc
viral
replic
promptli
third
articl
dr
jame
e
gern
overview
pathogenesi
clinic
implic
rhinoviru
vri
asthma
viral
infect
especi
caus
rhinoviru
common
caus
asthma
exacerb
dr
gern
review
sever
studi
demonstr
contribut
host
immun
respons
rhinoviru
ill
associ
rhinoviru
infect
exacerb
individu
establish
asthma
experiment
set
increas
cold
sever
associ
increas
airway
reactiv
measur
object
test
mechan
mucos
viral
infect
elicit
system
immun
respons
contribut
exacerb
area
activ
investig
complex
interact
incomplet
understood
present
import
question
must
answer
regard
frequenc
extent
viral
replic
lower
respiratori
tract
host
inflammatori
respons
infect
need
complet
character
patient
copd
elderli
also
risk
develop
seriou
lower
respiratori
tract
ill
caus
rhinovirus
dr
stephen
b
greenberg
review
topic
fourth
articl
discuss
find
prospect
observ
studi
older
ambulatori
adult
without
copd
monitor
sever
year
impact
rhinoviru
infect
popul
substanti
dr
greenberg
studi
found
picornavirus
identifi
rhinovirus
common
pathogen
found
follow
parainfluenza
virus
coronavirus
influenza
less
common
high
immun
rate
popul
studi
vri
patient
copd
associ
higher
healthcar
util
rate
includ
hospit
furthermor
popul
unit
state
age
burden
diseas
increas
respect
medic
care
resourc
util
one
approach
decreas
diseas
burden
develop
vaccin
rhinoviru
serotyp
exist
howev
task
impract
given
low
likelihood
effect
vaccin
rhinoviru
infect
effect
antivir
medic
might
prove
benefici
reduc
burden
intervent
studi
target
popul
need
fifth
articl
dr
gwaltney
discuss
histor
perspect
recent
therapeut
trial
treatment
rhinoviru
vri
remind
us
import
rigor
test
common
cold
treatment
appropri
control
blind
condit
variabl
rel
short
natur
histori
ill
pauciti
object
measur
larg
potenti
placebo
effect
earlier
investig
comment
year
ago
pathogenesi
symptom
relat
host
immun
respons
viru
combin
earli
treatment
antivir
agent
antiinflammatori
compound
may
effect
therapeut
approach
vri
result
rhinoviru
viral
respiratori
pathogen
although
candid
antirhinovir
agent
current
investig
studi
date
establish
potenti
prevent
earli
treatment
rhinoviru
infect
select
antivir
agent
supplement
conclud
review
dr
joseph
bertino
burden
diseas
vri
associ
excess
antibiot
use
particularli
young
children
grow
problem
antibiot
resist
pathogen
respiratori
bacteria
dr
bertino
discuss
recent
survey
patient
physician
attitud
practic
confirm
signific
impact
vri
articl
also
summar
control
studi
indic
antibiot
therapi
gener
shown
clinic
benefit
reduct
complic
cold
purul
rhiniti
outlin
step
taken
facilit
introduct
antivir
clinic
practic
remind
us
limit
possibl
side
effect
overthecount
medic
commonli
use
vri
summari
articl
supplement
underscor
signific
burden
vri
result
rhinoviru
individu
suffer
health
care
practition
societi
whole
illustr
certain
patient
popul
clinic
consequ
vri
seriou
purpos
supplement
discuss
increasingli
recogn
import
rhinoviru
infect
person
without
comorbid
review
current
understand
rhinoviru
infect
pathophysiolog
light
newli
develop
agent
target
pathogen
